Thematische Bibliographien / Coronary heart disease

Inhaltsverzeichnis

Zeitschriftenartikel
Dissertationen
Bücher
Buchteile
Konferenzberichte
Berichte der Organisationen

Auswahl der wissenschaftlichen Literatur zum Thema „Coronary heart disease“

Autor: Grafiati

Veröffentlicht am 4. Juni 2021

Zuletzt aktualisiert am 29. Juli 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Coronary heart disease" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Coronary heart disease"

Nurmamadovna, Ishankulova Nasiba. „Coronary Heart Disease“. American Journal of Medical Sciences and Pharmaceutical Research 03, Nr. 02 (28.02.2021): 31–36. http://dx.doi.org/10.37547/tajmspr/volume03issue02-04.

Der volle Inhalt der Quelle

Annotation:

The article covers the etiology, pathogenesis, classification, diagnosis, clinical picture and treatment of coronary heart disease, provides a literature review. Cardiovascular disease (CVD) represents the leading cause of death among women as well as men. The number of deaths due to CVD in women are greater than in men. There are significant gender-related differences concerning CVD.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Shakhnoza, Iskandarova, und Amilova Asalya. „PREVENTION OF CORONARY HEART DISEASE“. American Journal of Medical Sciences and Pharmaceutical Research 04, Nr. 04 (01.04.2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Der volle Inhalt der Quelle

Annotation:

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Sudhakar, B. G. K. „Structural heart disease interventions“. Clinical Research and Clinical Trials 3, Nr. 5 (25.06.2021): 01–05. http://dx.doi.org/10.31579/2693-4779/042.

Der volle Inhalt der Quelle

Annotation:

Seed for invasive cardiology was sown in early part of nineties. Cardiac catheterization was actually pioneered by Werner Forssmann in 1929. However, credit for therapeutic interventional cardiology should go to US vascular radiologist, Charles Theodore Dotter for performing first peripheral arterial angioplasty [PTA] in 1964. Subsequently, a German cardiologist by name Andreas Gruentzig adapted the technique in 1974 to suit coronary artery disease and performed the first human coronary balloon angioplasty to treat blockage in coronary artery in 1977.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Windecker, S. „CORONARY DISEASE: Intervention in coronary artery disease“. Heart 83, Nr. 4 (01.04.2000): 481–90. http://dx.doi.org/10.1136/heart.83.4.481.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Gulnara, Asadova, und Djamalov Abdurakhman. „REMEDIES AND RECOMMENDATIONS CORONARY HEART DISEASES“. Eurasian Journal of Medical and Natural Sciences 03, Nr. 02 (01.02.2023): 224–28. http://dx.doi.org/10.37547/ejmns-v03-i02-p1-37.

Der volle Inhalt der Quelle

Annotation:

Prevention of coronary heart disease is a series of complex measures aimed at preventing the onset of the disease, the development and occurrence of possible (predictable) complications, which can be even fatal. Prevention of coronary heart disease is indicated for both sick people and healthy people who are at risk of developing the disease. Patients diagnosed with coronary heart disease are shown non-drug treatment, which is a complete or partial elimination of risk factors. Risk factors are any predisposing factors that increase the likelihood of developing or worsening a disease. Risk factors for coronary heart disease are fundamentally divided into removable and non-removable.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Jha, Dr Sudha, Dr Naved Ahmad, Dr Surya Kant Nagtilak und Dr Maheshwar Chawla. „Coronary Heart Disease, A Gift of Modern Civilization“. International Journal of Scientific Research 2, Nr. 11 (01.06.2012): 378–80. http://dx.doi.org/10.15373/22778179/nov2013/122.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Timmis, A. „Coronary disease: Acute coronary syndromes: risk stratification“. Heart 83, Nr. 2 (01.02.2000): 241–46. http://dx.doi.org/10.1136/heart.83.2.241.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Gulyabin, Konstantin Robertovich. „Coronary heart disease“. Spravočnik vrača obŝej praktiki (Journal of Family Medicine), Nr. 1 (2022): 63–66. http://dx.doi.org/10.33920/med-10-2201-09.

Der volle Inhalt der Quelle

Annotation:

Coronary heart disease is of great clinical importance in medical practice. The development of medical science makes it possible to introduce new modern methods of treating this disease. One of these is coronary artery bypass grafting, a modern method of treating coronary heart disease, which allows to reliably increase myocardial perfusion and prolong the life expectancy of patients with coronary heart disease.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lavie, Carl J., Gary Legwold und Michael E. DeBakey. „Coronary heart disease“. Postgraduate Medicine 102, Nr. 2 (August 1997): 210–15. http://dx.doi.org/10.3810/pgm.1997.08.285.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Williams, Samantha. „Coronary heart disease“. Nursing Standard 19, Nr. 51 (31.08.2005): 67–68. http://dx.doi.org/10.7748/ns.19.51.67.s58.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Dissertationen zum Thema "Coronary heart disease"

Brouilette, Scott Wayne. „Telomeres and coronary heart disease“. Thesis, University of Leicester, 2004. http://hdl.handle.net/2381/29899.

Der volle Inhalt der Quelle

Annotation:

Using mean telomere length as a marker of biological age, I show that: 1. Subjects with premature myocardial infarction (MI) have significantly shorter telomeres than age-sex matched, healthy, controls. The mean telomere length in MI subjects was similar to controls almost 11 years older. 2. Healthy young adult children of families with a strong history of premature MI have shorter telomeres than age matched children of families without such a history. 3. Shorter telomere lengths are associated with increase risk of subsequent CHD events in a prospective study. This analysis was carried out on samples collected in the West of Scotland Coronary Prevention Study (WOSCOPS). This randomised blinded trial was designated to examine the benefits of statin treatment on preventing CHD and showed a 30% reduction of events in those treated with pravastatin. Interestingly, my analysis showed that this benefit of statin is only seen in those subjects at higher risk of CHD based on their telomere length.;As the final part of the thesis I carried out a quantitative linkage trait (QTL) analysis in sib-pairs in an attempt to identify genetic loci regulating telomere length. I report the mapping of a major QTL on chromosome 12 that determines almost 50% of the inter-individual variation in mean telomere length.;These findings support a novel "telomere" hypothesis of CHD. They indicate that telomere biology is intimately linked to the genetic aetiology and pathogenesis of CHD. Specifically, the findings suggest that (i) those individuals born with shorter telomeres may be at increased risk of CHD (ii) rather than individual genes, a more global structural property of the genetic material may explain the familial basis of CHD (iii) variation in telomere length may explain, in part, the variable age of onset of CHD. The findings provide several new avenues for future research.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lee, Chi-hang. „Microvascular obstruction following percutaneous coronary intervention for coronary artery disease“. Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43278723.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Heiser, Claire Anne. „Personality predictors of coronary heart disease“. Thesis, Virginia Polytechnic Institute and State University, 1985. http://hdl.handle.net/10919/50027.

Der volle Inhalt der Quelle

Annotation:

Fifty percent of the diagnosed cases of coronary heart disease in the United States are of unknown etiology. This study proposed that five personality traits— achievement, dominance, aggression, succorance and Critical Parent—differentiate individuals with coronary heart disease manifestations. The ultimate goal of this research was to formulate a predictive profile of at-risk individuals of developing coronary heart disease. Cardiac rehabilitation units' participants from across the United States were recruited as subjects. Randomly selected cardiac rehabilitation units were sent an initial letter inquiring whether their staff would be willing to participate in the study by administering the instruments to their participants. Eight units from each of the 50 states were contacted. A total of fourteen units agreed to participate. One hundred sixty-nine subjects completed the Demographic Data Questionnaire and the Adjective Check List. Five scale scores, representing the five personality differentials, were analyzed. Comparison of the male subject population (n=135) and the male normative population (n=198) revealed no significant differences in terms of the five traits. Comparison of diagnostic subgroups of the subject population also revealed no significant differences. It was concluded that the subject population did not differ significantly from the normative population in terms of the five traits assess by the instrument used. The goal of a predictive profile was not realized due to this lack of findings.
Master of Science
incomplete_metadata

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lee, Chi-hang, und 李志恆. „Microvascular obstruction following percutaneous coronary interventionfor coronary artery disease“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43278723.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Danesh, John. „Chronic infection and coronary heart disease“. Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326020.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Kounali, Daphne. „Early growth and coronary heart disease“. Thesis, University of Southampton, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.436926.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Zapanta, Laurence (Laurence F. ). „Heart rate variability in mice with coronary heart disease“. Thesis, Massachusetts Institute of Technology, 2005. http://hdl.handle.net/1721.1/34118.

Der volle Inhalt der Quelle

Annotation:

Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, 2005.
Includes bibliographical references (leaves 69-71).
Heart rate variability (HRV), the beat-to-beat fluctuation of the heart rate, is a non-invasive test that measures the autonomic regulation of the heart. Assessment of HRV has been shown to predict the risk of mortality in patients after an acute myocardial infarction. Recently, the Krieger lab at MIT developed genetically engineered double knockout (dKO) mice that develop coronary artery disease accompanied by spontaneous myocardial infarctions and die at a very young age. This thesis investigated whether HRV could function as a prognostic indicator in the dKO mouse. A novel method for estimating physiological state of the mouse from the electrocardiogram using an innovative activity index was developed in order to compare HRV variables at different times while controlling for physiologic state. Traditional time and frequency domain variables were used to assess the prognostic power of HRV. Results have shown that none of the HRV variables were helpful in predicting mortality in the dKO mice. Mean heart rate showed some prognostic power, but it was not consistent in all the dKO mice. Finally, the activity index developed in this thesis provided a reliable metric for activity in mice as validated by a camera with motion detection.
by Laurence Zapanta.
S.M.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Rose, Edward Leslie. „Coronary heart disease in patients with peripheral vascular disease“. Thesis, University of Oxford, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.305544.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bagés, Nuri. „Psychosocial risk factors and coronary heart disease“. [Maastricht : Maastricht : Universiteit Maastricht] ; University Library, Maastricht University [Host], 2000. http://arno.unimaas.nl/show.cgi?fid=6899.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Chandola, Tarani. „Social inequality in coronary heart disease outcomes“. Thesis, University of Oxford, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285007.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Bücher zum Thema "Coronary heart disease"

National Heart, Lung, andlood Institute, Hrsg. Coronary heart disease. [Bethesda, Md.?]: U.S. Dept. of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2003.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Vlodaver, Zeev, Robert F. Wilson und Daniel J. Garry, Hrsg. Coronary Heart Disease. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-1475-9.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Sandler, Gerald, Hrsg. Coronary Heart Disease. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-010-9218-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Scottish Forum for Public Health Medicine., Scottish Needs Assessment Programme und Special Needs Action Programme, Hrsg. Coronary heart disease. Glasgow: Scottish Forum for Public Health Medicine, 1998.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

National Board for Nursing, Midwifery and Health Visiting for Scotland. Coronary heart disease. Edinburgh: The Board, 1998.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

National Dairy Council. Nutrition Service. Coronary heart disease. London: National Dairy Council, 1993.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Royal Colleges of Physicians of the United Kingdom. Committee on Health Promotion. Coronary heart disease. London: Faculty of Community Medicine of the Royal Colleges of Physicians of the United Kingdom, 1988.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Anne, Halliday, Ashwell Margaret und British Nutrition Foundation, Hrsg. Coronary heart disease. London: British Nutrition Foundation, 1992.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

1928-, Sandler Gerald, Hrsg. Coronary heart disease. Lancaster: MTP Press, 1987.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Petersen, Sophie. Coronary heart disease statistics. London: British Heart Foundation, 2002.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Buchteile zum Thema "Coronary heart disease"

Bergersen, Lisa, Susan Foerster, Audrey C. Marshall und Jeffery Meadows. „Coronary Angiography“. In Congenital Heart Disease, 143–50. Boston, MA: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-77292-9_23.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Whang, William. „Coronary Heart Disease“. In Encyclopedia of Behavioral Medicine, 557–59. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_396.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Whang, William. „Coronary Heart Disease“. In Encyclopedia of Behavioral Medicine, 503–5. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_396.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Gaff, Lisa. „Coronary heart disease“. In Dietetic and Nutrition Case Studies, 146–49. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119163411.ch38.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Tsuboi, Hirohito, Katsunori Kondo, Hiroshi Kaneko und Hiroko Yamamoto. „Coronary Heart Disease“. In Social Determinants of Health in Non-communicable Diseases, 41–52. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-1831-7_5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Feuerstein, Michael, Elise E. Labbé und Andrzej R. Kuczmierczyk. „Coronary Heart Disease“. In Health Psychology, 317–80. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4899-0562-8_10.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Gorog, Diana. „Coronary Heart Disease“. In The Interventional Cardiology Training Manual, 1–11. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-71635-0_1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Marie, Philippe, und Norma Whittaker. „Coronary Heart Disease“. In Disorders and Interventions, 88–115. London: Macmillan Education UK, 2004. http://dx.doi.org/10.1007/978-0-230-21399-9_6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Whang, William. „Coronary Heart Disease“. In Encyclopedia of Behavioral Medicine, 1–3. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4614-6439-6_396-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Schenck-Gustafsson, Karin. „Coronary Heart Disease“. In Handbook of Clinical Gender Medicine, 190–205. Basel: KARGER, 2012. http://dx.doi.org/10.1159/000336385.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Coronary heart disease"

Riyaz, Lubna, Muheet Ahmed Butt und Majid Zaman. „Ensemble Learning for Coronary Heart Disease Prediction“. In 2022 International Conference on Intelligent Technologies (CONIT). IEEE, 2022. http://dx.doi.org/10.1109/conit55038.2022.9848292.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Pareek, Vishakha, und R. K. Sharma. „Coronary heart disease detection from voice analysis“. In 2016 IEEE Students' Conference on Electrical, Electronics and Computer Science (SCEECS). IEEE, 2016. http://dx.doi.org/10.1109/sceecs.2016.7509344.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Lin, Shisong, Xiaodong Zhuang, Shiyun Huang, Yahui Liu, Linlin Shen und Xinxue Liao. „Face Analysis for Coronary Heart Disease Diagnosis“. In 2019 12th International Congress on Image and Signal Processing, BioMedical Engineering and Informatics (CISP-BMEI). IEEE, 2019. http://dx.doi.org/10.1109/cisp-bmei48845.2019.8966020.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mangathayaru, Nimmala, B. Padmaja Rani, V. Janaki, Lakshmi Sowmya Kotturi, Manasa Vallabhapurapu und G. Vikas. „Heart Rate Variability for Predicting Coronary Heart Disease using Photoplethysmography“. In 2020 Fourth International Conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud) (I-SMAC). IEEE, 2020. http://dx.doi.org/10.1109/i-smac49090.2020.9243316.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Runjing, Zhou, und Li Keyang. „Fisher classifier in diagnosis of coronary heart disease“. In 2011 4th International Congress on Image and Signal Processing (CISP). IEEE, 2011. http://dx.doi.org/10.1109/cisp.2011.6100787.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Malik, Varun, Ruchi Mittal, Ajay Rana, Irfan Khan, Pankaj Singh und Bashar Alam. „Coronary Heart Disease Prediction Using GKFCM with RNN“. In 2023 6th International Conference on Contemporary Computing and Informatics (IC3I). IEEE, 2023. http://dx.doi.org/10.1109/ic3i59117.2023.10398020.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Gonsalves, Amanda H., Fadi Thabtah, Rami Mustafa A. Mohammad und Gurpreet Singh. „Prediction of Coronary Heart Disease using Machine Learning“. In the 2019 3rd International Conference. New York, New York, USA: ACM Press, 2019. http://dx.doi.org/10.1145/3342999.3343015.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Ni, Jinhao, und Guanghua Ren. „Statistical Analysis of Factors Influencing Coronary Heart Disease“. In 2022 14th International Conference on Computer Research and Development (ICCRD). IEEE, 2022. http://dx.doi.org/10.1109/iccrd54409.2022.9730221.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Shirazi, Badrosadat Nategholeslam, Shiva Naghsh, Ali Akbar Safavi und Amir Sharafkhaneh. „Machine Learning-Based Prediction of Coronary Heart Disease“. In 2023 9th International Conference on Control, Instrumentation and Automation (ICCIA). IEEE, 2023. http://dx.doi.org/10.1109/iccia61416.2023.10506325.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Li Xia, Fu Yifei, Bai Jing, Tian xin und Li Fangjie. „Complexity analysis on heart rate variability of coronary heart disease patients“. In 2008 International Conference on Technology and Applications in Biomedicine (ITAB). IEEE, 2008. http://dx.doi.org/10.1109/itab.2008.4570590.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Coronary heart disease"

Zhang, Ruizhe, und Qingya Xie. A meta-analysis of cholesteryl ester transfer protein(CETP) gene rs708272(G>A) polymorphism in association with cornoary heart disease risk. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Juni 2023. http://dx.doi.org/10.37766/inplasy2023.6.0021.

Der volle Inhalt der Quelle

Annotation:

Review question / Objective: To seek the association of the CETP rs708272 polymorphism with CHD.To figure out if the carriers of allele rs708272-A reduce or increase the risk of CHD in comparison with carriers of allele rs708272-G under allele model, dominant model and recessive model. Condition being studied: The inclusion criteria of CHD:(1)the presence of stenosis≥50% in a minimum of one main segment of coronary arteries (the right coronary artery, left circumfex, or left anterior descending arteries) by coronary angiography.(2) symptoms representing angina pectoris, electrocardiographic changes, and elevations of cardiac enzymes based on the criteria of the World Health Organization. (3) a certifed record of coronary artery bypass graft or percutaneous coronary intervention were included in the study.The exclusion criteria of CHD :patients with congenital heart disease, cardiomyopathy, and valvular disease.Controls:the same populations as the cases and specifed to be without CAD, cardiovascular and cerebrovascular diseases, and peripheral atherosclerotic arterial disease.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Weng, JIeqiong, Jingfang Zhang, Ke Xu, Mengfei Yuan, Tingting Yao, Xinyu Wang und Xiaoxu Shen. Efficacy of Shexiang Baoxin Pills Combined with Statins on Blood Lipid Profile in Patients with Coronary Heart Disease: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0100.

Der volle Inhalt der Quelle

Annotation:

Review question / Objective: P（Population) ：Patients with coronary heart disease; I（Intervention) : Statins treatment in combination with Shexiang Baoxin pill; C（Comparison): Statins alone; O（Outcome）: Improvement of symptoms and blood lipids; S（Study design）：Clinical randomized trials. Eligibility criteria: To be included, trials were required to meet the following criteria: (1) patients were included in the studies according to diagnostic criteria of coronary heart disease established by the WHO, InternationalSociety of Cardiology and Association (ISCA), Internal Medicine, 7th edition ( IM-7th), Practice of InternalMedicine, 14th edition ( PIM-14th), Guidelines for the Diagnosis of Cardiovascular Diseases in InternalMedicine, 3rd edition (GIM-3rd) or conventional diagnostic criteria (CDC) including assessment of anginapectoris and electrocardiogram (ECG) results; (2) the study was conducted as a randomized controlled trial.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wang, Shuang, Aidong Liu, Zhilei Wang und Yue Zhang. Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of angina pectoris of coronary heart disease: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2021. http://dx.doi.org/10.37766/inplasy2021.11.0100.

Der volle Inhalt der Quelle

Annotation:

Review question / Objective: This study is the protocol for a systematic review to evaluate the Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of angina pectoris of coronary heart disease: a systematic review and meta-analysis. we conducted a systematic review and meta-analysis of published randomized clinical trials (RCTs) of such combined therapy in the treatment of angina pectoris of coronary heart disease, It provides a reliable scientific basis for clinicians to use this approach to treat angina pectoris of coronary heart disease. Information sources: We conducted a systematic search for relevant documents in the Chinese and English databases, and the search time is limited to November 23, 2021. The following eight databases are included : PubMed,EMBASE, Web of Science, The Cochrane Library, Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI), Chinese Science and Technology Periodical Database (VIP), Wanfang Database.Relevant journals were searched to trace the references included in the study. Other resources will be searched if necessary.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wei, Dongmei, Yang Sun und Hankang Hen. Effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention: A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0080.

Der volle Inhalt der Quelle

Annotation:

Review question / Objective: Can Baduanjin exercise improve the cardiac rehabilitation of patients with coronary artery disease after percutaneous coronary artery surgery? Condition being studied: Coronary heart disease (CHD), also known as coronary artery disease (CAD), is the single most common cause of death globally, with 7.4 million deaths in 2013, accounting for one-third of all deaths (WHO 2014). PCI has been shown to be effective in reducing mortality in patients with CHD. During follow-up, it has been shown that the benefits of PCI can be offset by the significant risks of coronary spasm, endothelial cell injury, recurrent ischemia, and even restenosis or thrombus. Numerous guidelines endorse the necessity for cardiac rehabilitation (CR), which is recommended for patients with chronic stable angina, acute coronary syndrome and for patients following PCI. Baduanjin have been widely practised in China for centuries, and as they are considered to be low risk interventions, their use for the prevention of cardiovascular disease is now becoming more widespread. The ability of Baduanjin to promote clinically meaningful influences in patients with CHD after PCI, however, still remains unclear.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Dong, Guoqi, Mengye Lu, Xiaoliang Wu, Hao Chen, Hongru Zhang und Yihuang Gu. Network meta-analysis of Traditional Chinese medicines for depression in coronary heart disease patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Mai 2020. http://dx.doi.org/10.37766/inplasy2020.5.0036.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wienke, Andreas, Anne M. Herskind, Kaare Christensen, Axel Skytthe und Anatoli I. Yashin. The influence of smoking and BMI on heritability in susceptibility to coronary heart disease. Rostock: Max Planck Institute for Demographic Research, Januar 2002. http://dx.doi.org/10.4054/mpidr-wp-2002-003.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

McCausland, Rachel, Joann Fontanarosa und Ravi Patel. Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review. Agency for Healthcare Research and Quality (AHRQ), August 2023. http://dx.doi.org/10.23970/ahrqepcrapidcoronary.

Der volle Inhalt der Quelle

Annotation:

Aims. There is uncertainty around the optimal role of percutaneous coronary intervention (PCI) for management of chronic coronary syndrome, specifically when patients have disease in multiple coronary vessels and disease in the proximal portion of the left anterior descending coronary artery. This uncertainty was reflected in 2021 guidance from the American College of Cardiology (ACC)/American Heart Association (AHA) on coronary artery revascularization. The Agency for Healthcare Research and Quality has commissioned this rapid response literature review to meet a Congressional request for a summary of recent evidence on the benefits of angioplasties conducted in nonemergency situations. Methods. This rapid response literature review on the comparative effectiveness of nonemergent PCI followed established best systematic review methods, modified to meet a shortened project timeframe. We searched PubMed®, Embase®, and the Trip© medical database from 2018 through April 2023 for systematic reviews (SRs), clinical practice guidelines, and randomized controlled trials, and summarized the evidence comparing PCI to optimal medical therapy (OMT) for stable ischemic heart disease (SIHD). Our primary outcomes of interest were major objective cardiovascular outcomes, including mortality, myocardial infarction, stroke, urgent revascularization, or composites of one or more of these hard clinical outcomes. Where available, we also abstracted patient reported outcomes (e.g., angina severity and quality of life [QoL]) from included studies. Findings. Key findings from nine SRs and one primary study include: • The body of evidence directly comparing PCI to OMT for SIHD has remained largely unchanged since the 2021 ACC/AHA guidance’s publication. • Most studies of revascularization for coronary artery disease do not focus on direct head-to-head comparisons of PCI versus OMT for SIHD but instead either (1) compare OMT to invasive revascularization (PCI and coronary artery bypass graft [CABG] combined cohort); (2) compare PCI to CABG; or (3) compare different PCI techniques. • Another factor that complicates comparison is that the meta-analyses often included data from CABG and PCI combined cohorts (e.g., the recent landmark ISCHEMIA trial) but reported the outcomes as PCI specific. • In the general SIHD population, our review did not find evidence to support survival benefit or effect on hard clinical outcomes when PCI is added to OMT. • Limited evidence indicates there may be a beneficial effect of PCI on angina symptoms and measures of QoL, but most systematic reviews focused on major objective cardiovascular outcomes and did not consider QoL or freedom from angina. • Both OMT and PCI have evolved significantly during the period of time in which the systematic reviews’ included studies were conducted. It is not clear how these changes may have affected the applicability of past studies to current practice. Conclusions. The evidence directly comparing PCI to OMT for SIHD has remained largely unchanged since publication of the 2021 ACC/AHA guidelines. More research is needed to verify the comparative effectiveness of nonemergent PCI compared to medical treatment for individuals with SIHD, and how the effectiveness varies by certain patient populations and clinical presentation.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

li, jixu, shengdong iao, pengpeng Liang, Jie Cui und weimin Jiang. Meta-analysis of timing of IABP implantation for CABG in patients with coronary heart disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2023. http://dx.doi.org/10.37766/inplasy2023.8.0083.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Alobaidi, Larsa. Exploring the Links Between Gut Bacteria-Related Metabolites, Coronary Artery Disease (CAD) Risk, and Heart Failure (HF). Ames (Iowa): Iowa State University, Dezember 2023. http://dx.doi.org/10.31274/cc-20240624-703.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Cai, Ruping, Yuli Xu und Qiang Su. Meta-analysis of blood lipid reduction for patients with coronary heart disease by combination of pitavastatin and ezetimibe. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Mai 2021. http://dx.doi.org/10.37766/inplasy2021.5.0072.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!